Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 13.09-1,872.7511.327.3013.65

What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS is 13.09 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202513.09
Mar2024-1,872.75
Mar202311.32
Mar20227.30
Mar202113.65

How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 13.09
Positive
Mar2024 -1872.75
Negative
Mar2023 11.32
55.07
Mar2022 7.3
-46.52
Mar2021 13.65 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹110.0 Cr -0.9% -18.3% -63.2% Stock Analytics
ADANI ENTERPRISES ₹286,323.0 Cr 2.5% 9.8% 5.7% Stock Analytics
REDINGTON ₹19,122.2 Cr -2.7% -6.9% -2.8% Stock Analytics
HONASA CONSUMER ₹9,997.0 Cr 1.9% 14.5% 33.6% Stock Analytics
MMTC ₹9,225.0 Cr -1% -10.9% 8.1% Stock Analytics
LLOYDS ENTERPRISES ₹8,133.5 Cr -3.3% -8.5% 16% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.9%

-18.3%

-63.2%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses